Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa daga Jiannan Wang

Zane Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa daga Jiannan Wang mai nasara ne mai daraja sosai na 2023 Kyautar A' Design Award ta Baƙin Ƙarfe a Rukunin Gasar Ra'ayi.

Baƙin ƘarfeRa'ayi· 2023

Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa

daga Jiannan Wang

Abokin Ciniki: Contec Medical Systems Co., Ltd.

Mai Nasarar Kyautar A' Design Award ta Baƙin Ƙarfe a Rukunin Ra'ayi

1,026,301

Mai Nasara da Aka Tabbatar

Tabbatar da Matsayin Kyauta na #142135

Duba a A' Design Award Sanarwar Manema Labarai Alamar Kyauta

Launuka

Ƙirar

Game da Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa

Remoltra tsari ne na duban dan sauti mai launi (color doppler ultrasound) da za a yi amfani da shi daga nisa, wanda an tsara shi domin tsofaffi da kuma marasa lafiya masu naƙasa waɗanda ba za su iya tafiya asibiti ba. Tsarin ya kunshi na'urar daukar hoto da ake ajiye a asibiti da kuma karamar na'ura ta gida da ake kai wa majiyyacin. Majiyyacin zai kwanta ya sanya na'urar gida a bisa sashin jikinsa na sama. Fasahar Intanet na Abubuwa (Internet of Things) tana haɗa na'urorin biyu, ta yadda likita zai iya motsa alkalami mai amsa karfi (force feedback pen) domin jagorantar hannun robot da yake dauke da na'urar bincike (probe). Ana dawo da bayanan juriyar fata (skin resistance) zuwa alkalamin, wanda ke ba wa likita damar tantance matakin matsin lamba ko da yana nesa.

Amincewa

Game da Kyautar A' Design Award ta Baƙin Ƙarfe

Zanen Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa ya lashe Kyautar A' Design Award ta Baƙin Ƙarfe, wata karramawa mai daraja da ake bai wa kyawawan zane-zane waɗanda ke cika buƙatun ƙwararru da masana'antu da ake tsammani daga ƙirƙire-ƙirƙire da aka tsara da kyau. Waɗanda suka lashe kyautar Baƙin Ƙarfe suna nuna babban ƙwarewa, ƙwarewa ta musamman, fahimtar ƙwararru da ikon ƙirƙira na masu ƙirƙirar su. Ana sa ran zanen Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa ya zama ƙirƙira da ake girmamawa sosai, ake sha'awa da ƙauna wacce ke da amfani kuma mai sababbin abubuwa. Wannan zane da ya lashe Kyautar A' Design Award ta Baƙin Ƙarfe yana haɗa mafi kyawun ayyukan fannin kuma yana da halayen fasaha masu cancanta da ke da alaƙa da sanin yadda da baiwa. Ana girmama zanen Remoltra Remote Ultrasound System Tsarin Duban Dan Sauti Mai Nisa saboda cikakkiyar kulawarsa kuma an tsara shi don ba da ingantuwar rayuwa da ke taimakawa wajen mai da duniya wuri mafi kyau.

Bayan Ƙirar

Kayan Manema Labarai

Bayanin ƙungiyar, membobinta da cikakkun bayanai na fasaha da mai ƙirar ya bayar.

Siffofi Na Musamman: Remoltra color doppler ultrasound diagnostic system is meant to solve the problem when the aged and the disabled can not go to the hospital and the doctor can not visit home, by sending a domestic testing device to the patient's home. Through IoT technology, the doctor can operate the imaging device in the hospital to real-time control the probe on the home device that covers the patient, to conduct a professional test and make precise diagnosis.
Girma da Fakitin: Size of the hospital imaging device is 1300mm x 830mm x 710mm, the size of the home device is 498mm x 378mm x 500mm
Kalmomin Alama: Ultarsound imaging, Remote medical testing,Remote diagnosis, Home medical test, Force feedback
Fasahar Samarwa: Color doppler ultrasound imaging technolgy is used to make diagnosis. IoT technology is used to connect the home device and the imaging device in the hospital. Force feedback technology is to let the doctor feel real resistence that probe on the home device sences to know when to stop pressing the patient's skin.
Ƙalubalen Zane: The chanllange of this project is the real-time force feedback system. When the force-feedback pen on the imaging device is being operated, the prode on the home device, which is far away in the patient's home should better respond as quick as possible to minimize the delay. Through IoT technology it's possible to make real but the less delay, the better experience the patient would have.
Bincike: Special group of people like the aged or the disabled,are in serious needs of professional medical test and diagnosis done at their home. Therefore a series of research was conduct, investigating how they behave at home, and how the doctor usually conduct an ultrasonid diagnosis in the hospital. Then, all the ultrasond testing solution available on the market were searched and compared to find their dropbacks and advantages to solve the problem. After all those research, an concept of a testing system consists of two devices was come up with its unique service design and diagnostic process.
Wahayi: Chaos that happened in the world has made the world unsafe where people in serious needs of professional medical test and diagnosis, specially the aged and the disabled, are facing greater difficulties going out to the hospital. Or for a remote place where a doctor can't visit and provide on-site medical help. But they still need care and can't be forgotten.
Tsawon Lokacin Aikin: This project started in 2022 March in Changsha and Qinhuangdao, China, and the technology inside is still developing. It needs famous design award to prove that it needs more resources to make this design real
Tsarin Aiki: By online booking, the home device is sent to the patient's home. The patient needs to lie down the put the home device to cover the upper torso while the doctor in the hospital boots up the imaging device and connect the home device. Then with the touch screen showing the position of the probe, the doctor handholds the force feedback pen and move do different positions while the robotic arm does the same and transmit the skin resistence data back to the pen to let the doctor feel the force.
Godiyar Hotuna: #1: Creator Jiannan Wang, Remoltra, 2022.
#2: Creator Jiannan Wang, Remoltra, 2022.
#3: Creator Jiannan Wang, Remoltra, 2022.
#4: Creator Jiannan Wang, Remoltra, 2022.
#5: Creator Jiannan Wang, Remoltra, 2022.
Video Credits: Creator Jiannan Wang, Remoltra, 2022.